Integra LifeSciencesIART
About: Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Employees: 3,946
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
2,639% more call options, than puts
Call options by funds: $10.6M | Put options by funds: $388K
6% less funds holding
Funds holding: 237 [Q2] → 222 (-15) [Q3]
7.51% less ownership
Funds ownership: 98.26% [Q2] → 90.75% (-7.51%) [Q3]
22% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 65
24% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 82
45% less capital invested
Capital invested by funds: $2.26B [Q2] → $1.24B (-$1.01B) [Q3]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Citigroup Joanne Wuensch 62% 1-year accuracy 29 / 47 met price target | 2%upside $22 | Sell Maintained | 5 Nov 2024 |
Truist Securities Richard Newitter 86% 1-year accuracy 36 / 42 met price target | 3%downside $21 | Hold Maintained | 14 Oct 2024 |
Financial journalist opinion
Based on 4 articles about IART published over the past 30 days
